The TULSA Procedure has demonstrated postitive prostate whole-gland ablation outcomes with a PSA reduction of 95%2
The TULSA Procedure has demonstrated effective volume
reduction of 92% with sparing of the urethra and urinary
sphincter, after whole-gland ablation.1,2
The TULSA Procedure is FDA cleared, has more than 20 clinical publications with up to a 5-year outcomes. This procedure is incision-free and is performed as an outpatient procedure. Some of the many benefits include a low complication rate and a rapid recovery time.
Based on our most recent data, the TULSA Procedure has a relatively low risk of everyday functional decline because your physician has the ability to avoid important nerve bundles and structures around your prostate, decreasing the risk of side effects.
The TULSA Procedure is a one-and-done procedure, performed in a single session that takes a few hours. There is no need for repeat visits, meaning you can take less time off work, spend less time in the hospital, and spend more time living.
If you are in need of future prostate care, you may either have a repeat TULSA Procedure, or choose any other type of prostate therapy to address your prostate needs.
Most patients return to activities quickly and their erectile and urinary functions return to baseline in about 3 months
The TULSA Procedure is a customizable procedure that is personalized based on your unique anatomy and tissue.
The TULSA Procedure is precise which allows for local control of clinically significant disease, with significant PSA reduction and low rates of residual cancer on follow-up biopsy.2
Some risks associated with the TULSA Procedure may include the inability to get or maintain an erection, urine leakage, blood in the urine, urethral discharge, urinary tract infection, deep vein thrombosis, tightening of the bladder outlet and/or urethra requiring additional intervention, and potential worsening of urinary symptoms, including increased frequency and/or urgency and the need to urinate at night.